Business · Companies · 13 hrs ago
Sanofi says Gulf partners are helping shape medical innovation
Sanofi says the Gulf is moving from importing medical innovation to helping create it.
The French drugmaker has operated in the region for decades, with a Dubai hub that supplies more than 22 million medicine packs a year.
In Saudi Arabia, Sanofi is transferring technology to make insulin locally and working with partners to localize testing for five rare disorders.
In the UAE, the company says it runs 26 clinical studies at 32 sites, and the country recently approved two of its therapies before any other country.
The company is also working with Gulf universities and health services on research and tools to identify patients earlier, including people at risk of rare or genetic conditions.
These efforts matter because Gulf health systems are seeking more local capacity and a shift from treating illness to preventing it.
Sanofi expects more than 35 regional launches by 2030, and its work with Abu Dhabi’s health department aims to speed vaccine research and prepare for regional manufacturing.
Sanofi says it is working with Gulf partners to shape medical innovation rather than simply import it.
The company expects this work to support more than 35 new regional launches by 2030.
In Saudi Arabia, Sanofi is transferring technology to manufacture insulin locally and partnering on diagnostic testing for rare disorders.
In the UAE, Sanofi reports 26 clinical studies across 32 sites, involving more than 230 patients.
The company is also working with health authorities and institutions on research, early screening and the use of AI in healthcare.
- Who
- Sanofi and its Gulf partners, including health authorities, universities and healthcare organizations.
- What
- Sanofi says it is collaborating on medical research, local manufacturing, diagnostics and healthcare tools.
- When
- The report was published on October 21, 2026. More than 35 regional launches are expected by 2030.
- Where
- Across the Gulf, including Saudi Arabia and the UAE.
- Why
- Sanofi says the partnerships aim to shape healthcare innovation locally, strengthen regional capacity and support more predictive care.
This story does not have two clearly opposing sides.
Sanofi’s regional operations have been anchored by a logistics hub in Dubai.
The UAE became the first country to approve two Sanofi therapies, according to the company.
Sanofi expects its work to support more than 35 new regional launches.
- Dubai logistics hub
- Delivers more than 22 million packs of medicines a year across regional markets
- Regional launches
- More than 35 expected by 2030
- UAE clinical research
- 26 studies across 32 sites, involving more than 230 patients
- Rare-disorder testing
- Diagnostic testing is being localized for five lysosomal storage disorders
- AI pre-diagnosis tool
- accelRare covers more than 300 conditions and can generate a differential pre-diagnosis within minutes
What people are saying
Today, however, we are no longer just importing global science; we are co-creating the future of healthcare with local partners.
The Gulf doesn’t wait for global innovation — it leads it.
True health system resilience means catching signals before a crisis hits.